Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Psychedelic Opportunity You Need to Know About

When Stockhouse Editorial last caught up with Toronto-based CYBIN Inc. ( N.CYBN , OTC: CYBN , Forum ) back in September 2020 , the psychedelic life sciences company was just going public…and to much fanfare. Cybin is a life sciences company that views psychedelic subst...
Dave Jackson | October 19, 2021 |

Buzz on the Bullboards: Winners & Losers in Energy, Tech, & Cannabis

(Hexo Corp. stock chart – May 2021 to August 2021. Click to enlarge) Markets on Bay Street and Wall Street have seen a tumultuous close ride as we near the end of the summer season. Three of the biggest contributors to recent growth (and recent dips) are the tech, e...
Stockhouse Editorial | August 25, 2021 |

Meet the Company out to Finance the Electric Revolution

(Image via Glencore / Electric Royalties Ltd.) When it comes to the Electric Vehicle (EV) revolution, the future is imminent and those who have adopted this next level lifestyle agree that what they need is a lot of power … and a lot of resources. For invest...
Jonathon Brown | March 16, 2021 |

Technical Analyst Update on Black Tusk Resources

Technical analyst Clive Maund charts the explorer and discusses recent trading in the stock. Although our buying towards the end of May didn't succeed in triggering a breakout by Black Tusk Resources Inc. (TUSK:CSE; BTKRF:OTCMKTS; 0NB:FSE) , it rose a bit and it...
Streetwise Reports | June 16, 2020 |

Unnatural Distortions and the Precious Metals

I was sitting in my den looking out over the swamp—er—lake tonight when it appeared as though something was flailing around near the shoreline. So I threw on my deck shoes and went for a stroll down to the water to see what all the commotion was about. Now, you must under...
Streetwise Reports | June 8, 2020 |

Central Bank Hypnosis

One look at the chart of the U.S. financial markets against the backdrop of economic paralysis and suffering, and one is immediately filled with a myriad of emotions. Sympathy for those that have been afflicted by the most recent pandemic; fear for the families whose prim...
Streetwise Reports | June 2, 2020 |

The Inflation–Deflation Conundrum

As I sit here on the shores of lovely Lake Scugog, its weed-infested waters lying in wait for countless unsuspecting propellers soon to be ensnared, I am reminded of the failed world of central banking and policy initiatives, which too has become ensnared in flora of its ...
Streetwise Reports | May 27, 2020 |

Gold and Oil: Remembering the '70s

Before I get started on my weekly commentary, I want to thank you all for the waterfall of responses to A Boomer's Plea posted last weekend, in what I must confess was my most impassioned missive of a multi-decade writing career. Speaking out as a member of the generat...
Streetwise Reports | April 28, 2020 |

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'

The ways in which Moderna is to use the funds are explained and an update on its coronavirus vaccine is provided in a ROTH Capital Partners report. In an April 19 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that the Biomedical Advanc...
Streetwise Reports | April 23, 2020 |

Underowned and Underloved

Back in the Dark Ages, before cellular phones and the Internet, I was studying to complete the Ontario Securities course one afternoon when I came across the part discussing "asset allocation" and "portfolio construction." This section covered the recommended mix of bonds...
Streetwise Reports | April 14, 2020 |
1 2